What are the treatment options for postherpetic neuralgia (PHN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2025 • View editorial policy

From the Guidelines

Postherpetic neuralgia (PHN) treatment options are primarily focused on managing pain, with first-line treatments including gabapentin, pregabalin, tricyclic antidepressants, and topical lidocaine or capsaicin patches.

Treatment Options

  • Gabapentin: a commonly used first-line treatment, with a typical adult regimen titrating to 2400 mg per day in divided doses 1
  • Pregabalin: considered for patients with inadequate response to gabapentin, particularly for post-herpetic neuralgia 2, 1
  • Tricyclic antidepressants: effective for PHN, but may have cardiac toxicity concerns, especially in patients with ischemic cardiac disease or ventricular conduction abnormalities 3
  • Topical lidocaine or capsaicin patches: useful for localized peripheral neuropathic pain, with capsaicin patches providing sustained pain relief for up to 12 weeks 4 ### Additional Considerations
  • Opioids: may be considered for acute neuropathic pain or episodic exacerbations of severe pain, but with caution due to potential for dependence and side effects 3
  • Non-pharmacological treatments: should be evaluated and initiated if appropriate, as part of a comprehensive pain management plan 3
  • Referral to a pain specialist: may be necessary if trials of first-line medications alone and in combination fail to provide adequate pain relief 3

From the Research

Treatment Options for Postherpetic Neuralgia (PHN)

The treatment options for PHN can be classified into several categories, including:

  • Pharmacologic interventions, such as tricyclic antidepressants, anticonvulsants, and opioids 5
  • Topical treatments, such as lidocaine patches and capsaicin 5, 6
  • Interventional treatments, such as epidural injections and pulsed radiofrequency of the dorsal root ganglion (DRG) 6
  • Alternative therapies, such as electroacupuncture (EA) and osteopathic manipulative treatment (OMT) 7
  • Investigational drugs, such as AT2R antagonists, VGCC α2δ subunit inhibitors, and NGF inhibitors 8

First-Line Treatments

First-line treatments for PHN include:

  • Tricyclic antidepressants, such as nortriptyline 5, 6
  • Gabapentin, an anticonvulsant 5, 7, 6
  • Pregabalin, an anticonvulsant 7, 6
  • 5% lidocaine patches, a topical treatment 7, 6

Combination Therapy

Combination therapy, using multiple treatments simultaneously, may be more effective than monotherapy for some patients 7

  • Local anesthesia and gabapentin have been shown to have outstanding compatibility 7

Emerging Treatments

Emerging treatments for PHN include:

  • Cryoanalgesia, a non-freezing technique using liquid nitrogen spray 9
  • Investigational drugs, such as crisugabalin, mirogabalin, and fulranumab 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.